RPA and Rad51 constitute a cell intrinsic mechanism to protect the cytosol from self DNA

Nature Communications

Volumn 7, Issue , 2016, Pages

  Wolf, Christine ^a   Rapp, Alexander ^b   Berndt, Nicole ^a   Staroske, Wolfgang ^c   Schuster, Max ^a   Dobrick Mattheuer, Manuela ^a   Kretschmer, Stefanie ^a   König, Nadja ^a   Kurth, Thomas ^c   Wieczorek, Dagmar ^d   Kast, Karin ^a   Cardoso, M Cristina ^b   Günther, Claudia ^a   Lee Kirsch, Min Ae ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP AMP SYNTHASE; EXONUCLEASE; EXONUCLEASE TREX1; INTERFERON; PROTEIN P53; RAD51 PROTEIN; REPLICATION FACTOR A; SINGLE STRANDED DNA; SMALL INTERFERING RNA; SYNTHETASE; UNCLASSIFIED DRUG; EXODEOXYRIBONUCLEASE; PHOSPHOPROTEIN; PROTEIN BINDING; THREE PRIME REPAIR EXONUCLEASE 1;

ANTIMICROBIAL ACTIVITY; CELLS AND CELL COMPONENTS; CYTOLOGY; DEFENSE MECHANISM; DNA; GENOTOXICITY; IMMUNE SYSTEM; INJURY; MEMBRANE; MOLECULAR ANALYSIS; MUTATION; VIRUS;

ARTICLE; AUTOIMMUNITY; CELL NUCLEUS MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; CYTOSOL; DNA DAMAGE; DNA DEGRADATION; DNA REPAIR; DNA REPLICATION; ENZYME ACTIVITY; FEMALE; FIBROBLAST; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE ACTIVATION; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; PROTEIN DNA BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; CELL CULTURE; CYTOLOGY; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM;

CELLS, CULTURED; CYTOSOL; DNA, SINGLE-STRANDED; EXODEOXYRIBONUCLEASES; FIBROBLASTS; HEK293 CELLS; HELA CELLS; HUMANS; INTERFERON TYPE I; PHOSPHOPROTEINS; PROTEIN BINDING; RAD51 RECOMBINASE; REPLICATION PROTEIN A; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84971228925     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11752     Document Type: Article

References (55)

1. Atianand, M. K. & Fitzgerald, K. A. Molecular basis of DNA recognition in the immune system. J. Immunol. 190, 1911-1918 (2013).
2. Lindahl, T. & Wood, R. D. Quality control by DNA repair. Science 286, 1897-1905 (1999).
3. Hoss, M. et al. A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J. 18, 3868-3875 (1999).
4. Mazur, D. J. & Perrino, F. W. Identification and expression of the TREX1 and TREX2 cDNA sequences encoding mammalian 3' - 45' exonucleases. J. Biol. Chem. 274, 19655-19660 (1999).
5. Crow, Y. J. et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat. Genet. 38, 917-920 (2006).
6. Rice, G. et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am. J. Hum. Genet. 80, 811-815 (2007).
7. Richards, A. et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat. Genet. 39, 1068-1070 (2007).
8. Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat. Genet. 39, 1065-1067 (2007).
9. Namjou, B. et al. Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort. Genes Immun. 12, 270-279 (2011).
10. Crow, Y. J. et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat. Genet. 38, 910-916 (2006).
11. Rice, G. I. et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat. Genet. 41, 829-832 (2009).
12. Rice, G. I. et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat. Genet. 44, 1243-1248 (2012).
13. Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598 (2008).
14. Gall, A. et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120-131 (2012).
15. Ablasser, A. et al. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J. Immunol. 192, 5993-5997 (2014).
16. Gray, E. E., Treuting, P. M., Woodward, J. J. & Stetson, D. B. Cutting edge: cGAS is required for lethal autoimmune disease in the Trex1-deficient mouse model of Aicardi-Goutieres syndrome. J. Immunol. 195, 1939-1943 (2015).
17. Gao, D. et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proc. Natl Acad. Sci. USA 112, E5699-E5705 (2015).
18. Yang, Y. G., Lindahl, T. & Barnes, D. E. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131, 873-886 (2007).
19. Gunther, C. et al. Defective removal of ribonucleotides from DNA promotes systemic autoimmunity. J. Clin. Invest. 125, 413-424 (2015).
20. Kretschmer, S. et al. SAMHD1 prevents autoimmunity by maintaining genome stability. Ann. Rheum. Dis. 74, e17 (2015).
21. Bochkarev, A. & Bochkareva, E. From RPA to BRCA2: lessons from singlestranded DNA binding by the OB-fold. Curr. Opin. Struct. Biol. 14, 36-42 (2004).
22. Mine, J. et al. Real-time measurements of the nucleation, growth and dissociation of single Rad51-DNA nucleoprotein filaments. Nucleic Acids Res. 35, 7171-7187 (2007).
23. Civril, F. et al. Structural mechanism of cytosolic DNA sensing by cGAS. Nature 498, 332-337 (2013).
24. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013).
25. Herzner, A. M. et al. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat. Immunol. 16, 1025-1033 (2015).
26. Fujimoto, M. et al. RPA assists HSF1 access to nucleosomal DNA by recruiting histone chaperone FACT. Mol. Cell 48, 182-194 (2012).
27. Peng, G. et al. Genome-wide transcriptome profiling of homologous recombination DNA repair. Nat. Commun. 5, 3361 (2014).
28. Meindl, A. et al. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 42, 410-414 (2010).
29. Sestili, P. The fast-halo assay for the assessment of DNA damage at the single-cell level. Methods Mol. Biol. 521, 517-533 (2009).
30. Lorenz, H., Hailey, D. W. & Lippincott-Schwartz, J. Fluorescence protease protection of GFP chimeras to reveal protein topology and subcellular localization. Nat. Methods 3, 205-210 (2006).
31. Snapp, E. L. et al. Formation of stacked ER cisternae by low affinity protein interactions. J. Cell Biol. 163, 257-269 (2003).
32. Zou, L. & Elledge, S. J. Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300, 1542-1548 (2003).
33. Toledo, L. I. et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088-1103 (2013).
34. Gonzalez-Prieto, R., Munoz-Cabello, A. M., Cabello-Lobato, M. J. & Prado, F. Rad51 replication fork recruitment is required for DNA damage tolerance. EMBO J. 32, 1307-1321 (2013).
35. Zellweger, R. et al. Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells. J. Cell Biol. 208, 563-579 (2015).
36. Reijns, M. A. et al. Enzymatic removal of ribonucleotides from DNA is essential for mammalian genome integrity and development. Cell 149, 1008-1022 (2012).
37. Hiller, B. et al. Mammalian RNase H2 removes ribonucleotides from DNA to maintain genome integrity. J. Exp. Med. 209, 1419-1426 (2012).
38. Taniguchi, T. & Takaoka, A. A weak signal for strong responses: interferonalpha/beta revisited. Nat. Rev. Mol. Cell Biol. 2, 378-386 (2001).
39. Lindahl, T., Karran, P. & Wood, R. D. DNA excision repair pathways. Curr. Opin. Genet. Dev. 7, 158-169 (1997).
40. Guo, J., Hanawalt, P. C. & Spivak, G. Comet-FISH with strand-specific probes reveals transcription-coupled repair of 8-oxoGuanine in human cells. Nucleic Acids Res. 41, 7700-7712 (2013).
41. Marechal, A. & Zou, L. RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response. Cell Res. 25, 9-23 (2015).
42. Krejci, L., Altmannova, V., Spirek, M. & Zhao, X. Homologous recombination and its regulation. Nucleic Acids Res. 40, 5795-5818 (2012).
43. Lukacs, G. L. et al. Size-dependent DNA mobility in cytoplasm and nucleus. J. Biol. Chem. 275, 1625-1629 (2000).
44. Shimizu, N., Kamezaki, F. & Shigematsu, S. Tracking of microinjected DNA in live cells reveals the intracellular behavior and elimination of extrachromosomal genetic material. Nucleic Acids Res. 33, 6296-6307 (2005).
45. Gehrke, N. et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39, 482-495 (2013).
46. Lebon, P. et al. Intrathecal synthesis of interferon-alpha in infants with progressive familial encephalopathy. J. Neurol. Sci. 84, 201-208 (1988).
47. Ramantani, G. et al. Expanding the phenotypic spectrum of lupus erythematosus in Aicardi-Goutieres syndrome. Arthritis Rheum. 62, 1469-1477 (2010).
48. Rice, G. I. et al. Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 12, 1159-1169 (2013).
49. Peschke, K. et al. Deregulated type I IFN response in TREX1-associated familial chilblain lupus. J. Invest. Dermatol. 134, 1456-1459 (2014).
50. Ronnblom, L., Alm, G. V. & Eloranta, M. L. Type I interferon and lupus. Curr. Opin. Rheumatol. 21, 471-477 (2009).
51. Hasan, M. et al. Trex1 regulates lysosomal biogenesis and interferonindependent activation of antiviral genes. Nat. Immunol. 14, 61-71 (2013).
52. Clifford, R. et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 123, 1021-1031 (2014).
53. Ahn, J. et al. Inflammation-driven carcinogenesis is mediated through STING. Nat. Commun. 5, 5166 (2014).
54. Yan, N., Regalado-Magdos, A. D., Stiggelbout, B., Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11, 1005-1013 (2010).
55. Colombo, S. F., Longhi, R. & Borgese, N. The role of cytosolic proteins in the insertion of tail-anchored proteins into phospholipid bilayers. J. Cell Sci. 122, 2383-2392 (2009).